Expressomal approach for comprehensive analysis and visualization of ligand sensitivities of xenoestrogen responsive genes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 41, 2013, Pages 16508-16513

  Shioda, Toshi ^a,b   Rosenthal, Noël F ^a   Coser, Kathryn R ^a   Suto, Mizuki ^a   Phatak, Mukta ^c   Medvedovic, Mario ^c   Carey, Vincent J ^b,d   Isselbacher, Kurt J ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ESTROGEN; LIGAND; TRANSCRIPTOME; UNCLASSIFIED DRUG; XENOBIOTIC AGENT; XENOESTROGEN;

ARTICLE; CALCULATION; CELL STRAIN MCF 7; GENE; GENE ACTIVATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

BENZHYDRYL COMPOUNDS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE DISRUPTORS; ESTROGENS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ONTOLOGY; HUMANS; MCF-7 CELLS; MICROARRAY ANALYSIS; PHENOLS; RNA, MESSENGER;

EID: 84885367691     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1315929110     Document Type: Article

References (31)

1. Vom Saal FS, Nagel SC, Coe BL, Angle BM, Taylor JA (2012) The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol Cell Endocrinol 354(1-2): 74-84.
2. Schug TT, Janesick A, Blumberg B, Heindel JJ (2011) Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 127(3-5):204-215.
3. Zoeller RT, et al. (2012) Endocrine-disrupting chemicals and public health protection: A statement of principles from The Endocrine Society. Endocrinology 153(9):4097-4110.
4. Diamanti-Kandarakis E, et al. (2009) Endocrine-disrupting chemicals: An Endocrine Society scientific statement. Endocr Rev 30(4):293-342.
5. Cederroth CR, Zimmermann C, Nef S (2012) Soy, phytoestrogens and their impact on reproductive health. Mol Cell Endocrinol 355(2):192-200.
6. Chamorro-García R, et al. (2013) Transgenerational inheritance of increased fat depot size, stem cell reprogramming, and hepatic steatosis elicited by prenatal exposure to the obesogen tributyltin in mice. Environ Health Perspect 121(3):359-366.
7. Zoeller TR (2010) Environmental chemicals targeting thyroid. Hormones (Athens) 9(1): 28-40.
8. Vandenberg LN, et al. (2012) Hormones and endocrine-disrupting chemicals: Lowdose effects and nonmonotonic dose responses. Endocr Rev 33(3):378-455.
9. Taylor JA, et al. (2012) Dose-related estrogen effects on gene expression in fetal mouse prostate mesenchymal cells. PLoS ONE 7(10):e48311.
10. Do RP, Stahlhut RW, Ponzi D, Vom Saal FS, Taylor JA (2012) Non-monotonic dose effects of in utero exposure to di(2-ethylhexyl) phthalate (DEHP) on testicular and serum testosterone and anogenital distance in male mouse fetuses. Reprod Toxicol 34(4):614-621.
11. Hill AB (1965) The environment and disease: Association or causation? Proc R Soc Med 58:295-300.
12. vom Saal FS, et al. (2010) Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research. Toxicol Sci 115(2):612-613; author reply 614-620.
13. Myers JP, Zoeller RT, vom Saal FS (2009) A clash of old and new scientific concepts in toxicity, with important implications for public health. Environ Health Perspect 117(11):1652-1655.
14. Vandenberg LN, et al. (2013) Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. Reprod Toxicol 38:1-15.
15. Almstrup K, et al. (2002) Dual effects of phytoestrogens result in u-shaped doseresponse curves. Environ Health Perspect 110(8):743-748.
16. Li L, Andersen ME, Heber S, Zhang Q (2007) Non-monotonic dose-response relationship in steroid hormone receptor-mediated gene expression. J Mol Endocrinol 38(5):569-585.
17. Goodman A, Schorge J, Greene MF (2011) The long-term effects of in utero exposures-The DES story. N Engl J Med 364(22):2083-2084.
18. Kidd KA, et al. (2007) Collapse of a fish population after exposure to a synthetic estrogen. Proc Natl Acad Sci USA 104(21):8897-8901.
19. Soto AM, Justicia H, Wray JW, Sonnenschein C (1991) p-Nonyl-phenol: An estrogenic xenobiotic released from "modified" polystyrene. Environ Health Perspect 92:167-173.
20. Shor D, Sathyapalan T, Atkin SL, Thatcher NJ (2012) Does equol production determine soy endocrine effects? Eur J Nutr 51(4):389-398.
21. Coser KR, et al. (2003) Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray. Proc Natl Acad Sci USA 100(24):13994-13999.
22. Shioda T, et al. (2006) Importance of dosage standardization for interpreting transcriptomal signature profiles: Evidence from studies of xenoestrogens. Proc Natl Acad Sci USA 103(32):12033-12038.
23. Wood SN (2006) Generalized Additive Models: An Introduction with R (Chapman and Hall/CRC, Boca Raton, FL).
24. Freudenberg JM, Sivaganesan S, Phatak M, Shinde K, Medvedovic M (2011) Generalized random set framework for functional enrichment analysis using primary genomics datasets. Bioinformatics 27(1):70-77.
25. Birnbaum LS (2012) Environmental chemicals: Evaluating low-dose effects. Environ Health Perspect 120(4):A143-A144.
26. Won Jeong K, Chodankar R, Purcell DJ, Bittencourt D, Stallcup MR (2012) Gene-specific patterns of coregulator requirements by estrogen receptor-α in breast cancer cells. Mol Endocrinol 26(6):955-966.
27. Klinge CM, Jernigan SC, Mattingly KA, Risinger KE, Zhang J (2004) Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. J Mol Endocrinol 33(2):387-410.
28. Carroll JS, et al. (2005) Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122(1): 33-43.
29. DuSell CD, McDonnell DP (2008) 27-Hydroxycholesterol: A potential endogenous regulator of estrogen receptor signaling. Trends Pharmacol Sci 29(10):510-514.
30. Evans RM, Scholze M, Kortenkamp A (2012) Additive mixture effects of estrogenic chemicals in human cell-based assays can be influenced by inclusion of chemicals with differing effect profiles. PLoS ONE 7(8):e43606.
31. Lindberg K, Helguero LA, Omoto Y, Gustafsson JA, Haldosén LA (2011) Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/ HER3 and upregulation of PTEN: Implications for tamoxifen sensitivity. Breast Cancer Res 13(2):R43.